SETTLE MYCOBACTERIUM CELL WALL FRACTION IMMUNOSTIMULANT

Kraj: Australia

Język: angielski

Źródło: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Składnik aktywny:

MYCOBACTERIUM CELL WALL FRACTION; GENTAMICIN

Dostępny od:

NOVAVIVE AUSTRALASIA PTY LTD

INN (International Nazwa):

mycobacterial cell wall fracti(1mg/mL)

Forma farmaceutyczna:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Skład:

MYCOBACTERIUM CELL WALL FRACTION UNGROUPED Active 1.0 mg/ml; GENTAMICIN ANTIBIOTIC Other 30.0 ug/ml

Sztuk w opakowaniu:

1.5mL; 6 x 1.5mL

Klasa:

VM - Veterinary Medicine

Wyprodukowano przez:

NOVAVIVE AUSTRALASIA

Grupa terapeutyczna:

HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL

Dziedzina terapeutyczna:

IMMUNOTHERAPY

Wskazania:

EQUINE RESPIRATORY TRACT INFECTIONS VIRA | INFECTIONS OF VIRAL ORIGIN

Podsumowanie produktu:

Poison schedule: 0; Withholding period: WHP: DO NOt USE less than 28 days befo re slaughter for human consumption.; Host/pest details: HORSE: [EQUINE RESPIRATORY TRACT INFECTIONS VIRA]; Poison schedule: 0; Withholding period: ; Host/pest details: HORSE: [EQUINE RESPIRATORY TRACT INFECTIONS VIRA]; An immunotherapeutic agent for use by or under the direction of a registered Veterinarian as an aid in the treatment of Equine Endometritis caused by Streptococcus zooepidemicus.

Status autoryzacji:

Registered

Data autoryzacji:

2023-07-01

Ulotka dla pacjenta

READ
ENCLOSED
LEAFLET
BEFORE
USING
PRODUCT
DIRECTIONS
FOR
USE
FOR
USE
ONLY
BY,
OR
UNDER
THE
DIRECTION
OF,
A
REGISTERED
VETERINARY
SURGEON.
Roll
thevial
gently
between
hands
to
ensure
homogeneous
suspension
before
injecting.
Airspace
has
been
provided
invialto
facilitate
mixing.
TRGTMTOT
OF
EQUINA
ENDQMETRITJL
"YUD
BY
_STMPTOEQECY._
_ZPQ'9IDEMJT;1LJ_
FOR
INTRAVENOUS
_I_
INTRAUTERINE
USE
ONLY.
Administer
the
total
contents
01
onevial
(1.5
mL)
by
intrauterine
instillation
with
a
sterile
catheter
orby
intravenous
injection
intothe
jugular
vein
during
the
eariyoestrus
period.
Treatment
may
be
rapeated
at
subsequent
natural
or
induced
oestrus
periods.
MEAT
WITHHOLDING
PERIOD
(HORSES):
DO
NOT
USE
lessthan28days
before
slaughter
for
human
consumption.
FIRST
AID:If
poisoning
occurs
contact
a
doctor
or
Poisons
Infonnation
Centre.
Phone
Australia
131126.
Disposal:
Dispose
of
empty
containers
and
outer
packaging
by
wrapping
with
paper
and
putting
in
garbage.
See
enclosed
leaflet.
Manufactul'lld
by:
Bioniche
Animal
Health
USA,
Inc.,
Athens,
Georgia
USA
U.S.
Veterinary
Licence
No.
289
Distributed
by:
Bioniche
Animal
Health
(NAsia)
Ply
Lld
ACN
006
949480
46
Seaton
Street,
Annidale
NSW
2350
Australia
Telephone:
1800
032355
Store
between
2·C
and
8·C.
(Refrigerate.
Donot
freeze.)
Project:
SETTLEAAsia
File
Name:
Bioniche
AAsia SETTLE
Carton
Date:
March
30,
2009
Artist:
MLS
Version:
1.2
D
Approved
&
Proceed
Signature
D
Amend
&
Resubmit
Date
63198_45012_6x1.5mL_primary_MPL_V01 3/4/2009 A4 81%, A3 100%
carton 85mm x 57 mm x 55 mm
APPROVED
LABEL
Info
PEST


Verified
63198_45012_1.5mL_immediate_MPL_V01 3/4/2009 A4 93%, A3 100% 43 mm x
20 mm
APPROVED
LABEL
FOR
ANIMAL
TREATMENT ONLY
SETTLE®
MYCOBACTERIUM
CELL
WALL
FRACTION
IMMUNOSTIMULANT
1 mg/mL Mycobacterium Cell
Wall
Fraction
Contains 30 mcg/mL Gentamicin as a preservative
For
intravenous
/
intrauterine
use only.
IndicatiQns
An
immunotherapeutic
agent
for
use as
an aid in the
treatment
of
equine endometritis caused by
_Streptococcus_
_zooepidemicus._
DIRECTIONS FOR USE:
FOR USE ONLY